Newly released 2014 Cancer Progress Report from the American Association for Cancer Research highlights the need for increased federal funding of cancer research.
1 in 10 patients with cancer would be more accurately diagnosed if their tumors were defined by cellular and molecular criteria.
A retrospective study identifies a potential link between NSAID use and breast cancer recurrence and overweight and obese women.
More research is warranted to determine the effectiveness of Botox® (onabotulinumtoxinA) injections in slowing the growth of tumors.
The new test is more sensitive than fecal occult blood tests but carries a higher risk of false-positives.
Early studies show that continual low-dose chemotherapy lessens toxicity.
After positive results, there is debate regarding the roll out of pasireotide for patients with pancreatic cancer undergoing surgery.
A review of data suggests that HPV testing alone every 3 years provides a high level of reassurance against cervical cancer.
While guidelines recommend against routine use, further investigation and data collection on this topic is warranted.
A review demonstrated an improvement with proton beam therapy compared with those who received photon intensity-modulated radiation therapy.
Use of statins in patients with colorectal cancer associated with reduced colorectal cancer-specific mortality.
Changes in adipose tissue precede the development of cachexia symptoms, and suggest a treatment approach.
Exposure to dim light at night increased tumor growth and resistance to tamoxifen; more research is needed before gleaning takeaways.
Oncologists can now provide patients a wide array of treatment options.
A National Cancer Policy Forum Workshop offered patient-centered insight on the protection of patients and their data in clinical trials.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|